Satellite symposia
Sponsored scientific presentations
Lunch symposium/workshop
Duration: 1 hour
Sponsored scientific presentations are an excellent opportunity to interact with delegates. All lunch symposia / workshops will be promoted
via an e-blast, on the congress website and in the pocket programme.
The cost for a lunch symposium / workshop includes rental and basic AV equipment (beamer, laptop, screen) and set
and dismantling within the time slot booked.
The content of the workshop must be submitted
to the congress Scientific committee for approval in advance (deadline 1 September 2022). The company may present
products (aimed at improving quality, care and patient service), either by means of scientific presentations and a
discussion forum, or with a practical session demonstrating the placement and use of medical material.
Sunset session
Duration: 40 minutes
The cost for a sunset session includes rental and basic AV equipment (beamer, laptop, screen) and set-up and
dismantling within the time slot booked.
These sessions are an excellent opportunity to interact with delegates. All sunset sessions will be promoted via an
e-blast, on the congress website and in the pocket programme.
The content of the session must be submitted to the congress Scientific committee for approval in advance (deadline
1 September 2022). The company may present products (aimed at improving quality, care and patient service), either
by means of scientific presentations and a discussion forum, or with a practical session demonstrating the placement
and use of medical material.
18 000 € – 30 000 €
depending on room size (160 – 960 seats)
Select your slot from the options below:
Monday / Tuesday – 960 seats € 30 000
Monday / Tuesday – 430 seats € 21 800
Monday / Tuesday – 330 seats € 19 800
Monday / Tuesday – 160 seats € 18 000
VIDEO RECORDING € 5 500

12 000 € – 20 000 €
Depending on room size (160 – 960 seats)
Select your slot from the options below:
Monday / Tuesday – 960 seats € 20 000
Monday / Tuesday – 430 seats € 15 000
Monday / Tuesday – 330 seats € 13 500
Monday / Tuesday – 160 seats € 12 000
PRODUCT PRESENTATION € 6 000

Lunch sessions take place from 12:45 till 13:45
Abbott (M1-2-3)
Mild Traumatic Brain Injury: Finally, light at the end of the tunnel
Peter Biberthaler (Germany)
EMCREG-International & Total CME (Hall A1)
Life-Threatening Intracranial Hemorrhage, Gastrointestinal, and Trauma-Related Bleeding in Anticoagulated Patients: Optimal Management in the Emergency Department
Chair: Brian Gibler (USA)
- Intracranial Hemorrhages and Anticoagulation Reversal in the ED – Barbra Backus (Netherlands)
- Life-Threatening GI Bleeds and Anticoagulation Reversal in the ED –Richard Body (UK)
- Life-Threatening Traumatic Bleeds and Anticoagulation Reversal in the ED – Martin Möckel (Germany)
E.Care (M4-5)
E.care ED (M4-5)
Customer experiences and New Functionalities
- Meine Erfahrungen mit E.care ED. Gregor Stolz (Germany)
- Allgemeine Erfahrungen mit E.care ED mit Fokus auf Pflege-Workflow inkl. Wertsachendokumentation. Wilfried Schnieder (Germany)
- Mobile Patient Intake. Martin Monninger & Bert Maes (Mesalvo – E.care – Belgium
MSD (Hall A2)
The role of the emergency department in optimizing outcomes in mild to moderate Covid-19 patients
Chair: Juan Gonzalez del Castillo (Spain), Sven Schellberg (Germany)
- COVID-19: State of the art. Juan Gonzalez del Castillo (Spain), Sven Schellberg (Germany)
- Patients with suspected Covid-19 presenting to the ED today. Juan Gonzalez del Castillo (Spain)
- At home COVID-19 treatment options. Sven Schellberg (Germany)
Qiagen (Hall A5)
Using rapid multiplex PCR syndromic testing to support pathogen detection for infectious diseases in the emergency department
Chair: Martí Juanola Falgarona (Qiagen)
- Overall value and benefits of syndromic testing in the emergency department. Donia Bouzid (France)
- Impact of rapid multiplex-PCR syndromic testing during covid-19 in an emergency department. Olivier Peyrony (France)
Siemens Healthineers (M1-2-3) (18:10-18:50)
The Value of High Sensitivity Troponin at the Point of Care
- High-sensitivity troponin at the point of care: What’s the added value? Richard Body (UK)
- Paradigm shift in the care of patients with ACS. How Atellica VTLi hs-cTnI assay can revolutionize the treatment pathway at the point of care. Johannes Neumann (Germany)
ThermoFisher (M4-5) – (18:10-19:10)
Acute Dyspnea in the ED: How Biomarkers help to solve the puzzle
Chairs: Matthew Reed (UK)
- Is this infection and how severe? Martin Möckel (Germany)
- Cardiovascular dyspnea – how can I know? Evangelos Giannitsis (Germany)
- Just fatigue or more? Differential diagnosis of infection in the ED with consideration of an elderly population. Juan Gonzalez del Castillo (Spain)
Lunch sessions take place from 12:45 till 13:45
Gilead (M1-2-3)
Routine testing for blood-borne viruses in emergency departments: Opportunities for EM societies advancing implementation
Chair: Hartmut Stocker (Germany)
- The burden of blood-borne viruses (BBV): The need for increased routine testing. Laura Hunter (UK)
- Best practice sharing: Differing approaches in the UK and Spain. Juan González del Castillo (Spain), Laura Hunter (UK)
- Implementing routine testing: Improving health outcomes for people with undiagnosed infection. Juan González del Castillo (Spain), Rachel Hill-Tout (UK), Laura Hunter (UK)
Quidel (M4-5)
The time is now – accelerate ACS management at the point-of-care
Chair: Barbra Backus, MD, PhD
- Future of high sensitive POC troponin in risk stratification in the prehospital setting – Barbra Backus, MD, PhD (15 minutes)
- Role of high sensitive POC troponin in risk stratification for acute coronary syndrome in the prehospital setting – Rudolf Tolsma, MSc, Ambulance IJsselland (15 minutes)
- High sensitive POC troponin in the ED: what matters? – Michael Wünning, Dr. med., Marienkrankenhaus Hamburg (15 minutes)
Baxter (M1-2-3) (18:10-18:50)
The vital role of the Emergency Department in the Patient’s Sepsis Pathway
Chair: Jim Connolly (UK)
Speakers: Ben Creagh-Brown (UK), Caroline Munday (UK)
Fisher & Paykel (M4-5) (18:10-18:50)
Nasal high-flow therapy in the Emergency Department
Alexander Spiel (Austria), Christoph Dodt (Germany)